For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.63 in the prior trading day, Codexis Inc (NASDAQ: CDXS) closed at $1.61, down -1.23%. In other words, the price has decreased by -$1.23 from its previous closing price. On the day, 0.98 million shares were traded. CDXS stock price reached its highest trading level at $1.66 during the session, while it also had its lowest trading level at $1.58.
Ratios:
Our goal is to gain a better understanding of CDXS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.02 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 1.78 whereas as Long-Term Debt/Eq ratio is at 1.70.
On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 01 ’25 when Opaleye Management Inc. sold 253,533 shares for $1.67 per share. The transaction valued at 422,766 led to the insider holds 179,989 shares of the business.
Opaleye Management Inc. sold 107,490 shares of CDXS for $188,108 on Nov 28 ’25. The 10% Owner now owns 188,522 shares after completing the transaction at $1.75 per share. On Nov 26 ’25, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, sold 5,000 shares for $1.74 each. As a result, the insider received 8,706 and left with 191,012 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 145422256 and an Enterprise Value of 155342256. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.75 while its Price-to-Book (P/B) ratio in mrq is 3.77. Its current Enterprise Value per Revenue stands at 2.935 whereas that against EBITDA is -2.848.
Stock Price History:
The Beta on a monthly basis for CDXS is 2.44, which has changed by -0.68677044 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $5.51, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is -13.31%, while the 200-Day Moving Average is calculated to be -32.50%.
Shares Statistics:
The stock has traded on average 1.06M shares per day over the past 3-months and 1196220 shares per day over the last 10 days, according to various share statistics. A total of 90.28M shares are outstanding, with a floating share count of 87.56M. Insiders hold about 3.06% of the company’s shares, while institutions hold 69.56% stake in the company. Shares short for CDXS as of 1765756800 were 5816699 with a Short Ratio of 5.51, compared to 1763078400 on 4902879. Therefore, it implies a Short% of Shares Outstanding of 5816699 and a Short% of Float of 6.550000000000001.
Earnings Estimates
Its stock is currently analyzed by 2.0 different market analysts. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.11 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.49 and -$0.68 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.49, with 2.0 analysts recommending between -$0.35 and -$0.63.
Revenue Estimates
7 analysts predict $35.83M in revenue for. The current quarter. It ranges from a high estimate of $44.6M to a low estimate of $32.1M. As of. The current estimate, Codexis Inc’s year-ago sales were $21.46MFor the next quarter, 7 analysts are estimating revenue of $14.39M. There is a high estimate of $19.02M for the next quarter, whereas the lowest estimate is $9.2M.
A total of 7 analysts have provided revenue estimates for CDXS’s current fiscal year. The highest revenue estimate was $76M, while the lowest revenue estimate was $63.6M, resulting in an average revenue estimate of $67.28M. In the same quarter a year ago, actual revenue was $59.34MBased on 6 analysts’ estimates, the company’s revenue will be $70.8M in the next fiscal year. The high estimate is $82.71M and the low estimate is $53.8M.
